Sbi Securities Co., Ltd. Corcept Therapeutics Inc Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 322 shares of CORT stock, worth $23,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
322
Previous 22
1363.64%
Holding current value
$23,695
Previous $2.51 Million
840.51%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
467Shares Held
83.4MCall Options Held
1.38MPut Options Held
2.71M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$452 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...